-
FDA Recommends Approval of Muraglitazar, But May Need To Reconsider; Which Antipsychotics Are More Dangerous?; Should CPOE Undergo Evaluation?; New Treatment for Tennis Elbow; FDA Actions
-
A recent journal of the American College of Cardiology contains a Focus Issue section, consisting of 3 articles about PROVE IT-TIMI 22 and a state of the art paper ...
-
Colchicine added to conventional therapy for acute pericarditis reduced the recurrence rate and corticosteroids increased it.
-
The majority of chronic stable coronary artery disease patients given 75 mg of EC aspirin daily have adequate inhibition of COX, but younger, heavier, and post MI patients may not.
-
The newest generation spiral CT scanner with 64 slices, thin detectors and faster X-ray tube rotation provides high-resolution, near motion-free coronary artery images.
-
Topiramate at a maintenance dose decreased the mean number of monthly headache days in children with frequent migraines. Tolerability of the medication in children was generally similar to placebo.
-
Patients will benefit from further studies to better define the pathophysiology of muscle cramps and to find more effective medications with fewer side-effects.
-
In a wide range of patients with acute MI, adding clopidogrel 75 mg daily to aspirin and other standard treatments (such as fibrinolytic therapy) safely reduces mortality and major vascular events ...
-
A substantial minority of patients deemed too good for intravenous tPA were unable to be discharged home.
-
Human T-cell lymphotropic virus type I (HTLV-1) is a human retrovirus and the etiologic agent for a progressive neurological disease called HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP).